Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutaka Tokuda

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2015
[Everolimus plus exemestane in postmenopausal patients with estrogen-receptor-positive advanced breast cancer - Japanese subgroup analysis of BOLERO -2]Yoshinori Ito, Norikazu Masuda, Hiroji Iwata, et al.
Cancer|December 6, 2011
Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastasesNaoki Niikura, Jun Liu, Naoki Hayashi, et al.
The Oncologist|January 27, 2011
Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysisNaoki Niikura, Jun Liu, Naoki Hayashi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 11, 2015
Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapyYoshimasa Kosaka, Yoshiaki Rai, Norikazu Masuda, et al.
Plos One|June 16, 2017
NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccinationYoshie Kametani, Ikumi Katano, Asuka Miyamoto, et al.
Oncology Reports|December 5, 2003
Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal, and gastric cancerMasaya Mukai, Shinkichi Sato, Hisao Nakasaki, et al.
Japanese Journal of Clinical Oncology|September 25, 2009
Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatmentYasuhiro Suzuki, Yutaka Tokuda, Yasuhiro Fujiwara, et al.
Breast Cancer (Tokyo, Japan)|March 12, 2015
Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011Junichi Kurebayashi, Yasuo Miyoshi, Takashi Ishikawa, et al.
International Journal of Clinical Oncology|April 6, 2013
Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancerYasuhiro Suzuki, Rin Ogiya, Risa Oshitanai, et al.
International Immunology|October 3, 2002
The in vivo development of human T cells from CD34(+) cells in the murine thymic environmentYuki Saito, Yoshie Kametani, Katsuto Hozumi, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 19, 2015
[Everolimus plus exemestane in postmenopausal patients with estrogen-receptor-positive advanced breast cancer - Japanese subgroup analysis of BOLERO -2]Yoshinori Ito, Norikazu Masuda, Hiroji Iwata, et al.
Cancer|December 6, 2011
Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastasesNaoki Niikura, Jun Liu, Naoki Hayashi, et al.
The Oncologist|January 27, 2011
Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysisNaoki Niikura, Jun Liu, Naoki Hayashi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 11, 2015
Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapyYoshimasa Kosaka, Yoshiaki Rai, Norikazu Masuda, et al.
Plos One|June 16, 2017
NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccinationYoshie Kametani, Ikumi Katano, Asuka Miyamoto, et al.
Oncology Reports|December 5, 2003
Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal, and gastric cancerMasaya Mukai, Shinkichi Sato, Hisao Nakasaki, et al.
Japanese Journal of Clinical Oncology|September 25, 2009
Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatmentYasuhiro Suzuki, Yutaka Tokuda, Yasuhiro Fujiwara, et al.
Breast Cancer (Tokyo, Japan)|March 12, 2015
Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011Junichi Kurebayashi, Yasuo Miyoshi, Takashi Ishikawa, et al.
International Journal of Clinical Oncology|April 6, 2013
Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancerYasuhiro Suzuki, Rin Ogiya, Risa Oshitanai, et al.
International Immunology|October 3, 2002
The in vivo development of human T cells from CD34(+) cells in the murine thymic environmentYuki Saito, Yoshie Kametani, Katsuto Hozumi, et al.
Pageof 13